The pharmaceutical industry is composed of two main groups: the research-based pharmaceutical industries (innovators) and the generic industries.  The former discovers and develops new medicines while the later replicates, manufactures and distributes the bioequivalent or biosimilar “copies”...

The establishment of a proper method to determine FRAND royalty rates is a highly debated issue for a variety of reasons. Standard Essential Patents (SEPs) have a huge impact on the market of technologies and, despite very useful for interoperability, fixation of pro-competitive and pro-consumer...

    Law No. 190/2014, included into the investment compact 2015, introduces the so called patent box, a system for the partial tax reduction of the revenues produced through IP rights ("intangibles"). A stagnant economical situation of R&D in IP rights, together with the...

Our new blog has been launched today. Stay focused on it and we will try to keep you informed. You can read new posts on this blog via the RSS feed.

This is a sample event description. You can edit this description as you wish or remove the entire event.